65 related articles for article (PubMed ID: 17964790)
21. STAT-1 expression in human glioblastoma and peritumoral tissue.
Haybaeck J; Obrist P; Schindler CU; Spizzo G; Doppler W
Anticancer Res; 2007; 27(6B):3829-35. PubMed ID: 18225539
[TBL] [Abstract][Full Text] [Related]
22. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
23. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
Forsberg S; Ostman A; Rollman O
Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
[TBL] [Abstract][Full Text] [Related]
24. Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII.
Mukherjee J; DeSouza LV; Micallef J; Karim Z; Croul S; Siu KW; Guha A
Cancer Res; 2009 Nov; 69(22):8545-54. PubMed ID: 19903856
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
[TBL] [Abstract][Full Text] [Related]
26. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
Emanuel SL; Hughes TV; Adams M; Rugg CA; Fuentes-Pesquera A; Connolly PJ; Pandey N; Moreno-Mazza S; Butler J; Borowski V; Middleton SA; Gruninger RH; Story JR; Napier C; Hollister B; Greenberger LM
Mol Pharmacol; 2008 Feb; 73(2):338-48. PubMed ID: 17975007
[TBL] [Abstract][Full Text] [Related]
27. EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.
Milanezi F; Carvalho S; Schmitt FC
Expert Rev Mol Diagn; 2008 Jul; 8(4):417-34. PubMed ID: 18598224
[TBL] [Abstract][Full Text] [Related]
28. Postnatal developmental changes in the expression of ErbB receptors in murine Pacinian cospucles.
González-Martínez T; Germana A; Catania S; Cobo T; Ochoa-Erena FJ; de Carlos F; Díaz-Esnal B; Vega JA
Neurosci Lett; 2007 Jun; 420(1):90-5. PubMed ID: 17512116
[TBL] [Abstract][Full Text] [Related]
29. Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases.
Scheithauer BW; Erdogan S; Rodriguez FJ; Burger PC; Woodruff JM; Kros JM; Gokden M; Spinner RJ
Am J Surg Pathol; 2009 Mar; 33(3):325-38. PubMed ID: 19065105
[TBL] [Abstract][Full Text] [Related]
30. Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Cancer Res; 2009 Oct; 69(20):7953-9. PubMed ID: 19808959
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathogenesis of vestibular schwannomas: insights for the development of novel medical therapies.
Miller C; Igarashi S; Jacob A
Otolaryngol Pol; 2012; 66(2):84-95. PubMed ID: 22500497
[TBL] [Abstract][Full Text] [Related]
32. Nerve growth factor receptor expression in heterotransplanted vestibular schwannoma in athymic nude mice.
Charabi S; Simonsen K; Charabi B; Jacobsen GK; Moos T; Rygaard J; Tos M; Thomsen J
Acta Otolaryngol; 1996 Jan; 116(1):59-63. PubMed ID: 8820351
[TBL] [Abstract][Full Text] [Related]
33. Identification of Predictive Proteins and Biological Pathways for the Tumorigenicity of Vestibular Schwannoma by Proteomic Profiling.
Xu J; Zhang Y; Shi Y; Yin D; Dai P; Zhao W; Zhang T
Proteomics Clin Appl; 2019 Sep; 13(5):e1800175. PubMed ID: 31120176
[TBL] [Abstract][Full Text] [Related]
34. Secondary intracanalicular extension of a primary intracochlear schwannoma.
Bassim MK; Ewend MG; Buchman CA
Otol Neurotol; 2007 Sep; 28(6):863-4. PubMed ID: 17287652
[No Abstract] [Full Text] [Related]
35. Expression of ABCA2 protein in human vestibular schwannoma and peripheral nerve.
Wang Y; Yamada K; Tanaka Y; Ishikawa K; Inagaki N
J Neurol Sci; 2005 May; 232(1-2):59-63. PubMed ID: 15850583
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor expression in sporadic vestibular schwannomas.
Brown CM; Ahmad ZK; Ryan AF; Doherty JK
Otol Neurotol; 2011 Jan; 32(1):158-62. PubMed ID: 21099731
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic targeting based on gene-expression profiling in vestibular schwannomas.
Peruzzi PP; Lonser RR
J Neurosurg; 2014 Dec; 121(6):1432-3. PubMed ID: 25245342
[No Abstract] [Full Text] [Related]
38. A six-foot lab rat.
Underwood A
Newsweek; 2006 Dec; 148(24):69-70, 73. PubMed ID: 17186889
[No Abstract] [Full Text] [Related]
39. Potential Molecular Biomarkers of Vestibular Schwannoma Growth: Progress and Prospects.
Zhang Y; Long J; Ren J; Huang X; Zhong P; Wang B
Front Oncol; 2021; 11():731441. PubMed ID: 34646772
[TBL] [Abstract][Full Text] [Related]
40. A Review of Drug Therapy in Vestibular Schwannoma.
Long J; Zhang Y; Huang X; Ren J; Zhong P; Wang B
Drug Des Devel Ther; 2021; 15():75-85. PubMed ID: 33447015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
